Business News: Immunology Drug Companies Alumis and Acelyrin to Merge
Alumis Inc. and ACELYRIN, INC. are set to merge. The companies announced a definitive merger agreement under which Alumis and ACELYRIN will merge in an all-stock transaction. The transaction is expected to close in the second quarter of 2025, subject to approval by the stockholders of both companies and satisfaction of other customary closing conditions. […]